重组牛碱性成纤维细胞生长因子外用凝胶联合施保利通治疗复发性口腔溃疡疗效观察

目的 观察重组牛碱性成纤维细胞生长因子外用凝胶联合施保利通治疗复发性口腔溃疡的临床疗效.方法 46例复发性口腔溃疡患者,按随机数字表法分为治疗组和对照组,治疗组22例在给予重组牛碱性成纤维细胞生长因子外用凝胶的基础上口服施保利通;对照组24例单纯给予西瓜霜喷剂治疗,治疗1周后观察疗效并进行比较.结果 治疗组治愈率高于对照组90.9％（20/22）比66.7％ （16/24）],差异有统计学意义（P＜0.05）.观察组疼痛消失、溃疡面缩小、溃疡面愈合的时间与对照组比较明显缩短,差异有统计学意义（P＜0.05）.结论 重组牛碱性成纤维细胞生长因子外用凝胶联合施保利通治疗复发性口腔溃疡能促进溃疡愈合,缩短病程,且无不良反应,值得临床推广应用.

Observation on the curative effect of recombinant bovine basic fibroblast growth factor gel combined with esberitox for recurrent oral ulcer

Objective To observe the clinical effect of recombinant bovine basic fibroblast growth factor gel combined with esberitox for recurrent oral ulcer.Methods Forty-six patients with recurrent oral ulcer were divided into treatment group of 22 patients and control group of 24 patients by random digits table method.The patients in treatment group were given recombinant bovine basic fibroblast growth factor gel and esberitox.The patients in control group were given the watermelon frost spray only.After treatment for 1 week,the curative effect was compared.Results The cure rate in treatment group was 90.9％ （20/22）,which was significantly higher than that in control group （66.7％,16/24）,and there was significant difference （P ＜0.05）.The time of pain vanish,oral ulcer decrease,oral ulcer healing in treatment group were significantly shorter than those in control group,and there were significant differences （P ＜0.05）.Conclusions Recombinant bovine basic fibroblast growth factor gel combined with esberitox for recurrent oral ulcer can promote ulcer healing,shorten the course of disease,and has no adverse reaction.It is worthy of applying in clinic.